Patents Assigned to Merck Patents GmbH
  • Publication number: 20180010046
    Abstract: The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerisable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment type.
    Type: Application
    Filed: December 17, 2015
    Publication date: January 11, 2018
    Applicant: Merck Patent GmbH
    Inventors: Qiong TONG, Helga HAAS, Thorsten KODEK, Peer KIRSCH, Constanze BROCKE, Eveline BARON, Christoph MARTEN
  • Publication number: 20180011359
    Abstract: The present application discloses a switchable device, comprising a switching layer and a first conductive layer and a second conductive layer, where the switching layer is positioned between the first and the second conductive layer, and where at least one of the first and the second conductive layers comprises a plurality of isolating sections and a plurality of conductive sections, where the isolating sections and the conductive sections alternate over the area of the conductive layer, and where the switching state of the switchable device is controlled by touch motions.
    Type: Application
    Filed: December 22, 2015
    Publication date: January 11, 2018
    Applicant: Merck Patent GmbH
    Inventors: Ties DE JONG, Casper Laurens VAN OOSTEN
  • Publication number: 20180013067
    Abstract: The present invention relates to formulations comprising at least one organic semiconductor and at least one organic solvent, characterized in that the formulation contains less than 10,000 particles per liter formulation having an average size in the range from 0.1 to 20 ?m, to their use for the preparation of electronic devices, to methods for preparing electronic devices using the formulations of the present invention, and to electronic devices prepared from such methods and formulations.
    Type: Application
    Filed: January 21, 2016
    Publication date: January 11, 2018
    Applicants: Merck Patent GmbH, Seiko Epson Corporation
    Inventors: Edgar BOEHM, Anja GERHARD, Dietmar KUNKEL, Volker HILARIUS, Uchida MASAHIRO, Sonoyama TAKUYA, Takei SHUICHI, Imamura KOJI
  • Patent number: 9862887
    Abstract: The instant invention relates to mesogenic media comprising one or more compounds of formula D wherein the parameters are as specified in the text, preferably to mesogenic media showing a blue phase, preferably stabilised by a polymer, and their use in electro-optical light modulation elements and their respective use in displays, as well as to such devices.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: January 9, 2018
    Assignee: Merck Patent GmbH
    Inventors: Michael Wittek, Malgorzata Rillich
  • Patent number: 9862219
    Abstract: The present invention relates to a method for producing a marking in a coating on a substrate or on the surface of a molding, where the marking represents a negative marking within a luminescent surrounding field and is generated using a laser beam, to a marking produced with the aid of the method, and to the use thereof, in particular for the labeling of products.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: January 9, 2018
    Assignee: MERCK PATENT GMBH
    Inventor: Sylke Klein
  • Patent number: 9861635
    Abstract: Compounds of the formula I in which X, Y, Q1, M, Q2 and B have the meanings indicated in Claim 1, are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: January 9, 2018
    Assignee: Merck Patent Gmbh
    Inventors: Guenter Hoelzemann, Dieter Dorsch, Ansgar Wegener, Oliver Poeschke, Michael Busch
  • Patent number: 9862717
    Abstract: The invention provides novel substituted indazole compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: January 9, 2018
    Assignees: Merck Patent GmbH, Cancer Research Technology Limited
    Inventors: Kai Schiemann, Aurelie Mallinger
  • Publication number: 20180002604
    Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds comprising a self-alignment additive for vertical alignment and additionally at least one compound of formula I as described more closely within this disclosure (polymerizable HALS), especially for vertically aligned display applications.
    Type: Application
    Filed: June 23, 2017
    Publication date: January 4, 2018
    Applicant: Merck Patent GmbH
    Inventors: Hyun-Jin YOON, Mi-Na PARK, Ji-Won JEONG, Eun-Kyu LEE, Min-Ok JIN, Yong-Kuk YUN
  • Publication number: 20180004045
    Abstract: The invention relates to a light modulation element comprising a cholesteric liquid crystalline medium sandwiched between two substrates (1), provided with a common electrode structure (2) and a driving electrode structure (3) individually, wherein the substrate with driving and/or common electrode structure is additionally provided with an alignment electrode structure (4) which is separated from the driving and or common electrode structure on the same substrate by a dielectric layer (5), characterized in that it comprises at least one alignment layer (6) directly adjacent to the liquid crystalline medium. The invention is further related to a method of production of said light modulation element and to the use of said light modulation element in various types of optical and electro-optical devices, such as electro-optical displays, liquid crystal displays (LCDs), non-linear optic (NLO) devices, and optical information storage devices.
    Type: Application
    Filed: December 30, 2015
    Publication date: January 4, 2018
    Applicant: Merck Patent GmbH
    Inventors: Kuan-Yu CHEN, Ming-Chou WU, Bernd FIEBRANZ, Harald SEIBERT
  • Publication number: 20180006092
    Abstract: The present invention relates inter alia to a color display comprising nanoparticles and color filters.
    Type: Application
    Filed: February 1, 2016
    Publication date: January 4, 2018
    Applicants: MERCK PATENT GMBH, YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: Bernhard RIEGER, Edgar BOEHM, Volker HILARIUS, Christof PFLUMM, Uri BANIN
  • Publication number: 20180002387
    Abstract: The present invention relates to the preparation and use of recombinant variants of group 5 allergens of the Poaceae (true grasses), which are characterised by reduced IgE reactivity compared with known wild-type allergens and at the same time substantially retained reactivity with T-lymphocytes.
    Type: Application
    Filed: September 11, 2017
    Publication date: January 4, 2018
    Applicant: Merck Patent GmbH
    Inventors: Martin WALD, Andreas NANDY, Helmut FIEBIG, Bernhard WEBER, Helga KAHLERT, Gerald REESE, Oliver CROMWELL
  • Publication number: 20180006253
    Abstract: An electronic component (10) comprising a plurality of switching elements (1) which comprise, in this sequence, a first electrode (16), a molecular layer (18) bonded to a substrate, and a second electrode (20), where the molecular layer essentially consists of molecules (M) which contain a connecting group (V) and an end group (E) having a polar or ionic function, is suitable as memristive device for digital information storage.
    Type: Application
    Filed: December 8, 2015
    Publication date: January 4, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Peer KIRSCH, Qiong TONG, Andreas RUHL, Marc TORNOW, Achyut BORA
  • Publication number: 20180002603
    Abstract: The present invention relates to liquid-crystalline media comprising one or more compounds of formula T and one or more compounds selected from the group of compounds of formulae I, II and III, in which the parameters have the meaning indicated in Claim 1, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
    Type: Application
    Filed: December 14, 2015
    Publication date: January 4, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Michael WITTEK, Dagmar KLASS
  • Patent number: 9859502
    Abstract: The invention relates to compounds according to formula (1), said compounds being suitable for use in electronic devices, in particular in organic electroluminescent devices.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: January 2, 2018
    Assignee: Merck Patent GmbH
    Inventors: Arne Buesing, Irina Martynova, Frank Voges, Jonas Valentin Kroeber
  • Patent number: 9856417
    Abstract: The invention relates to Eu2+-activated phosphors, to a process for the preparation of these compounds, and to phosphor mixtures, light sources and lighting units which comprise the Eu2+-activated phosphors according to the invention.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: January 2, 2018
    Assignee: Merck Patent GmbH
    Inventors: Ralf Petry, Holger Winkler, Tim Vosgroene, Christof Hampel, Andreas Benker, Thomas Juestel
  • Patent number: 9855268
    Abstract: Compounds of the formula I in which R1 and R2 have the meanings indicated in claim 1, are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: January 2, 2018
    Assignee: MERCK PATENT GMBH
    Inventors: Dieter Dorsch, Guenter Hoelzemann, Michel Calderini, Ansgar Wegener, Oliver Poeschke
  • Publication number: 20170369781
    Abstract: The present invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy (??), which is distinguished by the fact that it has a value for the ratio ?1/?n2 in the range 6-45 with a clearing point of >60° C. and a ?? of ??2.3. Media of this type are particularly suitable for electro-optical displays having active-matrix addressing based on the ECB, PA LCD, FFS or IPS effect.
    Type: Application
    Filed: August 15, 2017
    Publication date: December 28, 2017
    Applicant: Merck Patent GmbH
    Inventors: Melanie KLASEN-MEMMER, Sabine SCHOEN
  • Publication number: 20170369780
    Abstract: The invention relates to bimesogenic compounds of formula I to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.
    Type: Application
    Filed: October 23, 2015
    Publication date: December 28, 2017
    Applicant: Merck Patent GmbH
    Inventors: Kevin ADLEM, Owain Llyr PARRI, Rachel TUFFIN, Hassan ARASI, Thomas MACGREGOR
  • Publication number: 20170372903
    Abstract: The present invention relates to a process for the production of structured, highly efficient solar cells and of photovoltaic elements which have regions of different doping. The invention likewise relates to the solar cells having increased efficiency produced in this way.
    Type: Application
    Filed: December 1, 2015
    Publication date: December 28, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Oliver DOLL, Ingo KOEHLER, Sebastian BARTH
  • Publication number: 20170369784
    Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12 and CG1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.
    Type: Application
    Filed: December 2, 2015
    Publication date: December 28, 2017
    Applicant: MERCK PATENT GMBH
    Inventor: David WILKES